FDA bile duct if successful should lead to a rerate. So would TGA approval.
Both strategies were covered in the latest business update plus the conference call.
Plus, still have the private payer market, especially in London.
Plus as TT mentioned they may still be able to do some clinical studies in the UK and Germany as mentioned in the business update to support public reimbursement.
- Forums
- ASX - By Stock
- Ann: OncoSil Investor Update
FDA bile duct if successful should lead to a rerate. So would...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OSL (ASX) to my watchlist
|
|||||
Last
1.1¢ |
Change
0.001(4.76%) |
Mkt cap ! $41.62M |
Open | High | Low | Value | Volume |
1.0¢ | 1.1¢ | 1.0¢ | $36.16K | 3.384M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
25 | 14154999 | 1.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
1.1¢ | 5667943 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
25 | 14154999 | 0.010 |
21 | 12098472 | 0.009 |
9 | 6587500 | 0.008 |
7 | 3264285 | 0.007 |
9 | 8595001 | 0.006 |
Price($) | Vol. | No. |
---|---|---|
0.011 | 5667943 | 6 |
0.012 | 6817838 | 11 |
0.013 | 11057332 | 6 |
0.014 | 5769139 | 8 |
0.015 | 8500000 | 3 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
OSL (ASX) Chart |
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online